Immune evasion by cancer stem cells ensures tumor initiation and failure of immunotherapy
Authors:
- Sourio ChakrabortySCSourio Chakraborty
- Sumon MukherjeeSMSumon Mukherjee
- Udit BasakUBUdit Basak
- Subhadip PatiSPSubhadip Pati
- Apratim DuttaADApratim Dutta
- Saikat DuttaSDSaikat Dutta
- Subhanki DharSDSubhanki Dhar
- Tania SarkarTSTania Sarkar
- Aharna GuinAGAharna Guin
- Gaurisankar SaGSGaurisankar Sa
- Tanya DasTDTanya Das
Open Access
- 31 August 2023
- journal article
- review article
- Published by Open Exploration Publishing in Exploration of Immunology
- Vol. 3 (4) , 384-405
Abstract
Cancer stem cells (CSCs) are a small subpopulation of cells that drive the formation and progression of tumors. However, during tumor initiation, how CSCs communicate with neighbouring immune cells to overcome the powerful immune surveillance barrier in order to form, spread, and maintain the tumor, remains poorly understood. It is, therefore, absolutely necessary to understand how a small number of tumor-initiating cells (TICs) survive immune attack during (a) the “elimination phase” of “tumor immune-editing”, (b) the establishment of regional or distant tumor after metastasis, and (c) recurrence after therapy. Mounting evidence suggests that CSCs suppress the immune system through a variety of distinct mechanisms that ensure the survival of not only CSCs but also non-stem cancer cells (NSCCs), which eventually form the tumor mass. In this review article, the mechanisms via which CSCs change the immune landscape of the tissue of origin, which contains macrophages, dendritic cells (DCs), myeloid-derived suppressor cells (MDSCs), natural killer (NK) cells, and tumor-infiltrating lymphocytes, in favour of tumorigenesis were discussed. The failure of cancer immunotherapy might also be explained by such interaction between CSCs and immune cells. This review will shed light on the critical role of CSCs in tumor immune evasion and emphasize the importance of CSC-targeted immunotherapy as a cutting-edge technique for battling cancer by restricting communication between immune cells and CSCs.Keywords
This publication has 193 references indexed in Scilit:
- Tumor-infiltrating DCs suppress nucleic acid–mediated innate immune responses through interactions between the receptor TIM-3 and the alarmin HMGB1Nature Immunology, 2012
- Hallmarks of Cancer: The Next GenerationCell, 2011
- Immunoregulatory properties of CD44+ cancer stem‐like cells in squamous cell carcinoma of the head and neckHead & Neck, 2011
- Regulatory T cells in tumor immunityInternational Journal of Cancer, 2010
- Tumor heterogeneity: Causes and consequencesBiochimica et Biophysica Acta (BBA) - Reviews on Cancer, 2010
- Immune surveillance: a balance between protumor and antitumor immunityCurrent Opinion in Genetics & Development, 2008
- Checkpoint Blockade in Cancer Immunotherapy2006
- Stem cells, asymmetric division and cancerNature Genetics, 2005
- Immunotherapy and chemotherapy — a practical partnershipNature Reviews Cancer, 2005
- Different faces of regulatory DCs in homeostasis and immunityTrends in Immunology, 2005